Literature DB >> 5075463

The influence of progesterone and estradiol upon migraine.

B W Somerville.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5075463     DOI： 10.1111/j.1526-4610.1972.hed1203093.x

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  8 in total

1.  Acute estrogen surge enhances inflammatory nociception without altering spinal Fos expression.

Authors:  Andrew Ralya; Kenneth E McCarson
Journal:  Neurosci Lett       Date:  2014-05-24       Impact factor: 3.046

2.  Premenstrual tension: psychological aspects.

Authors:  A W Clare
Journal:  Ir J Med Sci       Date:  1983-06       Impact factor: 1.568

Review 3.  Current Treatment Options: Headache Related to Menopause-Diagnosis and Management.

Authors:  Clinton G Lauritsen; Abigail L Chua; Stephanie J Nahas
Journal:  Curr Treat Options Neurol       Date:  2018-03-06       Impact factor: 3.598

Review 4.  Defining gender disparities in pain management.

Authors:  Linda Leresche
Journal:  Clin Orthop Relat Res       Date:  2011-07       Impact factor: 4.176

Review 5.  Practical approaches to migraine management.

Authors:  Seymour Diamond; Richard Wenzel
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 6.  Hormonal influences in migraine - interactions of oestrogen, oxytocin and CGRP.

Authors:  Diana N Krause; Karin Warfvinge; Kristian Agmund Haanes; Lars Edvinsson
Journal:  Nat Rev Neurol       Date:  2021-09-20       Impact factor: 42.937

7.  Genetic association and gene expression studies suggest that genetic variants in the SYNE1 and TNF genes are related to menstrual migraine.

Authors:  Astrid J Rodriguez-Acevedo; Robert A Smith; Bishakha Roy; Heidi Sutherland; Rod A Lea; Alison Frith; E Anne MacGregor; Lyn R Griffiths
Journal:  J Headache Pain       Date:  2014-10-14       Impact factor: 7.277

Review 8.  Gender aspects of CGRP in migraine.

Authors:  Alejandro Labastida-Ramírez; Eloísa Rubio-Beltrán; Carlos M Villalón; Antoinette MaassenVanDenBrink
Journal:  Cephalalgia       Date:  2017-10-30       Impact factor: 6.292
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.